Showing results (381-390 of 783) with videos related to

Sort By:
Pageof 79
Antiviral Research|July 1, 1990
The efficacy of intranasal interferon alpha-2a in respiratory syncytial virus infection in volunteersP G Higgins, G I Barrow, D A Tyrrell, et al.
Pathology|April 1, 1993
The reliability of serological tests for the diagnosis of genital herpes: a critiqueP R Field, D W Ho, W L Irving, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2018
Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Robin D Isaacs, et al.
Immunotherapy Advances|December 25, 2025
A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritisCatherine A Lawson, Rachel Harry, Bridget Griffiths, et al.
Gastroenterology|November 1, 1985
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trialE Christensen, J Neuberger, J Crowe, et al.
Transfusion|July 21, 1999
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repairJ L Carson, D G Altman, A Duff, et al.
Tobacco Control|March 27, 1999
Predictors of crop diversification: a survey of tobacco farmers in North Carolina (USA)D G Altman, D J Zaccaro, D W Levine, et al.
Archives of Disease in Childhood|February 1, 1990
Neonatal pneumoniaS Webber, A R Wilkinson, D Lindsell, et al.
Rheumatology (Oxford, England)|July 5, 2016
Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit dataArthur G Pratt, Dennis Lendrem, Ben Hargreaves, et al.
The Journal of Rheumatology|June 1, 1996
Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1HJ D Isaacs, B L Hazleman, K Chakravarty, et al.
Pageof 79